Author Archives: ScienceSpeaks

CROI 2017: Coming “youth bulge” presents HIV responses with impetus, obstacles,…

Categories: CROI 2017SEATTLE – They are curious, impulsive and renownedly reckless. Studies have indicated they remain blissfully unaware of their risks, and unequipped to face them. Now, their numbers are growing fastest  in countries that are home to great risks — where rates of HIV infection are among the world’s highest and where current approaches to testing and treatment already […](Read more…)

Posted in Aid & Development, General Global Health, Global Health Events, HIV/AIDS, Infectious Disease | Tagged , | Comments closed

CROI 2017: Innovation, research tackle TB challenges

Categories: CROI 2017An “ultra”-sensitive test, and a proactive use of prednisone show promise, require monitoring SEATTLE – In the halting progress against tuberculosis in people living with HIV, advances in both diagnosis and effective treatment have come with gaps and caveats, highlighted, and then answered with research presented last week in sessions and press conferences dedicated to […](Read more…)

Posted in Infectious Disease, Research, Tuberculosis | Tagged , , | Comments closed

CROI 2017: Added support, speed and communication improve HIV service linkage and retention in…

Categories: CROI 2017SEATTLE – Providing immune cell testing and HIV treatment counseling immediately after a positive HIV test was the first in a series of measures that increased rapid linkage to care and retention at ten clinic sites in  Mozambique, data presented here Thursday showed. Measures in a randomized trial of interventions in Maputo and Inhambane Province also […](Read more…)

Posted in HIV/AIDS, Infectious Disease, Research | Tagged , , | Comments closed

CROI 2017: Targeted testing needed to reach 2020 goal, stronger systems needed to rise to the…

Categories: CROI 2017Findings from first three of 13 countries in the Population-based HIV Impact Assessment show significant progress, highlight need for focused outreach SEATTLE – Zambia, Zimbabwe and Malawi, neighboring countries all hit hard by HIV across their populations, have all made similar strides that go beyond dropping numbers of new infections to rising numbers of people getting the […](Read more…)

Posted in Conferences, HIV/AIDS, Infectious Disease, Policy & Systems | Tagged , , , , | Comments closed

CROI 2017: Continued Nix-TB regimen results take the kitchen sink out of XDR-TB treatment

Categories: CROI 2017Continued success of three-drug, six-month regimen introduces potential first gold standard of XDR-TB care SEATTLE – With a mortality rate of about 75 percent, tuberculosis that is extensively resistant to first and second-line treatments — XDR-TB — has left physicians with little choice aside from what Dr. Francesca Conradie calls the “kitchen sink” approach. That […](Read more…)

Posted in Infectious Disease, Tuberculosis | Tagged , , | Comments closed

CROI 2017: More evidence that TB preventive therapy saves lives of people with HIV highlights…

Categories: CROI 2017SEATTLE – At CROI 2015 the results of the TEMPRANO trial showed that early initiation of antiretroviral therapy and six months of isoniazid preventive therapy significantly reduced illness including tuberculosis in patients with HIV.  On Wednesday, Anani Badje from the TEMPRANO group provided long-term follow-up results from this same study that confirmed the value of […](Read more…)

Posted in Aid, Aid & Development, HIV/AIDS, Infectious Disease, Tuberculosis | Tagged , , | Comments closed

CROI 2017: A story of scientific collaboration, and resistance to travel ban highlight benefits…

Categories: CROI 2017SEATTLE – There was a time that when people thought of Zimbabwe, Dr. James Hakim said here Monday night, they thought of Victoria Falls, magnificent wildlife — the “Big Five” — and the graceful curves of Shona stone sculpture. That was before the HIV pandemic exploded in his country amidst crippling economic inflation and political denial that set […](Read more…)

Posted in Aid & Development, Human Rights, Infectious Disease | Tagged , | Comments closed

CROI 2017: With free treatment for citizens, but not for immigrants, Botswana sees progress,…

Categories: CROI 2017SEATTLE – On one hand, Botswana stands before the world, and certainly before its nearest neighbors as a model of determined and successful policies that confront one of the largest HIV burdens in the world. With possibly 22 percent of people there living with the virus, the country still is considered close to achieving the UNAIDS 90-90-90 […](Read more…)

Posted in Aid, Aid & Development, HIV/AIDS, Infectious Disease, Refugees & Immigrants | Tagged , , | Comments closed

CROI 2017: Study takes a look at real world impact of combination HIV prevention

Categories: CROI 2017Data shows combination of prevention measures working, but with more elements  needed SEATTLE – As an effective approach to controlling HIV, the value of “combination HIV prevention” is discussed often enough to be known by its initials: CHP. But as always when letters replace words, what they encompass , and if the whole of something called CHP is at least as […](Read more…)

Posted in Aid, Aid & Development, HIV/AIDS, Infectious Disease | Tagged , | Comments closed

CROI 2017: Continuing HIV treatment for new mothers in maternal and child health programs…

Categories: CROI 2017SEATTLE –  Providing antiretroviral therapy to pregnant women in antenatal care settings has become commonplace in sub-Saharan African settings, but keeping these women in care after their babies are born has been challenging.  Continuing antiretroviral treatment services for  women in settings where postnatal services are provided to them and their infants is a “simple and […](Read more…)

Posted in HIV/AIDS, Infectious Disease | Tagged , | Comments closed

Think scale! Engaging Private Pharmacies to Improve Public Health 

A version of this story first appeared on IDSA’s Science Speaks platform By Emily Delmotte Lisinopril 20 mg by mouth at 8am? Check. After verifying the Read More

Posted in Aid & Development, Featured Content, General Global Health, Health Workforce, Hub Originals, Infectious Disease, Medications & Treatments, Policy & Systems, Publications, Research, Tuberculosis | Tagged , , | Comments closed

What we’re reading: Making the case for, maintaining the impact of U.S. global health…

Categories: UncategorizedThe Vital Case for Global Health Investments by the United States Government – The cost effectiveness of controlling infectious disease outbreaks where they begin, the protection that improving health capacities globally offers American travelers and guest workers, the common good advanced by global health research, and the good will generated by humane international responses are […](Read more…)

Posted in General Global Health | Tagged | Comments closed

WHO calls for list of essential diagnostics

Categories: Research and DevelopmentLast June, a Perspective piece in the New England Journal of Medicine noted the critical place that the World Health Organization’s list of Essential Medicines had assumed in global health policy and responses — donors, governments and insurers were all more likely to invest in promoting accessibility of medicines that were on the list. The […](Read more…)

Posted in Aid, Aid & Development, General Global Health, Infectious Disease | Tagged , | Comments closed

115th Congress and Global Health: New Democrats for House State and Foreign Operations, Labor,…

Categories: Transition 2017, 115th CongressRep. Nita Lowey’s announcement of Democrat Appropriations subcommittee membership introduces two Democrats  to the House Appropriations State and Foreign Operations Subcommittee, and two to the Labor Health and Human Services and Education Subcommittee. House Appropriations State and Foreign Operations Subcommittee  Rep. David Price (D-NC) – Rep.

Posted in Infectious Disease | Tagged , | Comments closed